NVAX Stock Price
Novavax, Inc.
NVAX stock price is $12.64 (-1.40% on the day), giving Novavax, Inc. a market cap of $2.08B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
NVAX Stock Overview
- Price
- $12.64
- Previous close
- $12.82
- Open
- $12.69
- Market cap
- $2.08B
- P/E ratio
- 4.7
- 52-week range
- $6.20 - $13.38
- 1-year price target
- $13.90
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 60
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVAX | $12.64 | -1.4% | 8.48M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |